
DENOZEP-50 ER
MRP: 1,200
Packaging: 10x10
Pack Type: tablet
Composition:
Desvenlafaxine 50mg ER
Indication:
Major Depressive Disorders, Vasomotor Symptoms
Description:
Desvenlafaxine 50 mg ER is an extended-release serotonin-norepinephrine reuptake inhibitor (SNRI) prescribed to treat major depressive disorder (MDD). It works by increasing serotonin and norepinephrine levels in the brain, which helps elevate mood, relieve anxiety, and improve overall mental well-being.
The extended-release formulation allows for once-daily dosing and provides steady medication levels, enhancing compliance and minimizing side effects. It is suitable for adults and helps improve symptoms of depression, including low energy, sadness, and difficulty concentrating.
Tags:
- Effective treatment for major depressive disorder
- Reduces anxiety and improves overall mood
- Extended-release for convenient once-daily dosing
- Helps with energy, focus, and sleep regulation
- Generally well tolerated with manageable side effects
Usage Information
Dosage
Typical dose: 50 mg once daily, preferably in the morning Take with or without food Adjustments only under doctor supervision Do not abruptly discontinue medication
Side Effects
Common: Nausea Dizziness Dry mouth Sweating Insomnia or drowsiness Serious (seek medical attention): Suicidal thoughts or behavior Allergic reactions (rash, swelling) High blood pressure Serotonin syndrome symptoms (confusion, rapid heartbeat)
Contraindications
Hypersensitivity to Desvenlafaxine or ingredients Concurrent use with MAO inhibitors Pregnancy and breastfeeding caution advised Use with caution in patients with hypertension or bipolar disorder
Availability
Desvenlafaxine 50mg ER, extended-release antidepressant, SNRI medication, depression treatment, anxiety relief, mood stabilizer
